Padilha EC - Search Results

1

Application of in vitro Drug Metabolism Studies in Chemical Structure Optimization for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP).

Padilha EC, Wang J, Kerns E, Lee A, Huang W, Jiang JK, McKew J, Mutlib A, Peccinini RG, Yu PB, Sanderson P, Xu X. Padilha EC, et al. Front Pharmacol. 2019 Apr 24;10:234. doi: 10.3389/fphar.2019.00234. eCollection 2019. Front Pharmacol. 2019. PMID: 31068801 Free PMC article.

2

Preclinical Pharmacokinetics and In Vitro Properties of GS-441524, a Potential Oral Drug Candidate for COVID-19 Treatment.

Wang AQ, Hagen NR, Padilha EC, Yang M, Shah P, Chen CZ, Huang W, Terse P, Sanderson P, Zheng W, Xu X. Wang AQ, et al. Among authors: padilha ec. Front Pharmacol. 2022 Aug 16;13:918083. doi: 10.3389/fphar.2022.918083. eCollection 2022. Front Pharmacol. 2022. PMID: 36052127 Free PMC article.

3

NOX2 inhibitor GSK2795039 metabolite identification towards drug optimization.

Padilha EC, Shah P, Rai G, Xu X. Padilha EC, et al. J Pharm Biomed Anal. 2021 Jul 15;201:114102. doi: 10.1016/j.jpba.2021.114102. Epub 2021 Apr 26. J Pharm Biomed Anal. 2021. PMID: 33992989 Free PMC article.

4

Identification of Selective CYP3A7 and CYP3A4 Substrates and Inhibitors Using a High-Throughput Screening Platform.

Kabir M, Padilha EC, Shah P, Huang R, Sakamuru S, Gonzalez E, Ye L, Hu X, Henderson MJ, Xia M, Xu X. Kabir M, et al. Among authors: padilha ec. Front Pharmacol. 2022 Jul 1;13:899536. doi: 10.3389/fphar.2022.899536. eCollection 2022. Front Pharmacol. 2022. PMID: 35847040 Free PMC article.

5

A review of pharmacokinetic parameters of metabolites and prodrugs.

de Campos ML, Padilha EC, Peccinini RG. de Campos ML, et al. Among authors: padilha ec. Drug Metab Lett. 2014 Jul;7(2):105-16. doi: 10.2174/1872312808666140317155008. Drug Metab Lett. 2014. PMID: 24628402 Review.

6

UHPLC Quantitation Method for New Thiazolidinedione LPSF/GQ-02 and In Vitro/In Vivo Kinetic Studies.

Vieira CM, Campos ML, Padilha EC, Pitta M, Pitta ID, de Lima MD, Peccinini RG. Vieira CM, et al. Among authors: padilha ec. Drug Metab Lett. 2016;10(3):206-212. doi: 10.2174/1872312810666160725124554. Drug Metab Lett. 2016. PMID: 27456668

7

Biocompatible microemulsion modifies the tissue distribution of doxorubicin.

Candido CD, Campos ML, Correa Vidigal Assumpção JU, Pestana KC, Padilha EC, Carlos IZ, Peccinini RG. Candido CD, et al. Among authors: padilha ec. J Pharm Sci. 2014 Oct;103(10):3297-301. doi: 10.1002/jps.24106. Epub 2014 Aug 6. J Pharm Sci. 2014. PMID: 25100266

8

Metabolism and pharmacokinetics characterization of metarrestin in multiple species.

Padilha EC, Shah P, Wang AQ, Singleton MD, Hughes EA, Li D, Rice KA, Konrath KM, Patnaik S, Marugan J, Rudloff U, Xu X. Padilha EC, et al. Cancer Chemother Pharmacol. 2020 Apr;85(4):805-816. doi: 10.1007/s00280-020-04042-y. Epub 2020 Mar 17. Cancer Chemother Pharmacol. 2020. PMID: 32185484 Free PMC article.

9

Pharmacokinetics of hydroxymethylnitrofurazone and its parent drug nitrofurazone in rabbits.

Nogueira Filho MA, Padilha EC, Campos ML, Pontes Machado DV, Davanço MG, Pestana KC, Chin CM, Peccinini RG. Nogueira Filho MA, et al. Among authors: padilha ec. Drug Metab Lett. 2013 Mar;7(1):58-64. doi: 10.2174/18723128112069990013. Drug Metab Lett. 2013. PMID: 23957951

10

Pharmacokinetic and safety evaluation of the use of ciprofloxacin on an isoniazid-rifampicin regimen in rabbits.

Padilha EC, Pires RV, Filho MA, de Pontes Machado DV, Baldan HM, Davanço MG, Campos ML, Brunetti IL, Peccinini RG. Padilha EC, et al. Biopharm Drug Dispos. 2012 Dec;33(9):501-9. doi: 10.1002/bdd.1817. Epub 2012 Oct 25. Biopharm Drug Dispos. 2012. PMID: 23007681

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters